Improving Responses to Immunotherapy in Bladder Cancer – OncLive
|
Improving Responses to Immunotherapy in Bladder Cancer
OncLive There are many reasons why a tumor may not respond to immunotherapy. It may range from the fact that there are not sufficient antigens to the fact that the antigens are not presented or that the immune cells can’t get into the tumor. Or even if they … |
|
Global Stem Cell Partnering Report 2018: Access to Deals and Agreements by the World’s Leading Healthcare …
PR Newswire (press release) The report provides a detailed understanding and analysis of how and why companies enter Stem Cell partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and proceed to commercialization of outcomes. This report … |
Alphr |
What is gene therapy? The experimental technique could make untreatable diseases curable
Alphr Gene therapy is one of the most exciting fields in biotechnology right now, representing a major shift in medicine. It focuses not on treating symptoms of diseases with traditional drugs, but modifying underlying causes in a person’s genetic code. As a … |